Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ann Surg Oncol. 2024 Apr;31(4):2766-2776. doi: 10.1245/s10434-023-14861-x. Epub 2024 Jan 20.
Prepectoral implant placement for postmastectomy breast reconstruction has increased in recent years. Benefits of prepectoral reconstruction may include lack of animation deformities and reduced postoperative pain, but its complication profile is currently unclear. This study aimed to examine the complication profile of prepectoral tissue expanders (TEs) to determine factors associated with TE loss.
A retrospective review was performed to identify all patients who underwent immediate prepectoral TE reconstruction from January 2018 to June 2021. The decision to use the prepectoral technique was based on mastectomy skin quality and patient comorbidities. Patient demographics, comorbidities, and operative details were evaluated. Outcomes of interest included TE loss, seroma, hematoma, infection/cellulitis, mastectomy skin flap necrosis requiring revision, and TE exposure. Logistic regression analysis was performed to identify factors associated with TE loss.
The study identified 1225 TEs. The most frequent complications were seroma (8.7%, n = 106), infection/cellulitis (8.2%, n = 101), and TE loss (4.2%, n = 51). Factors associated with TE loss in the univariate analysis included ethnicity, history of smoking, body mass index, mastectomy weight, and neoadjuvant chemotherapy. In the multivariate regression analysis, only mastectomy weight had a positive association with TE loss (odds ratio, 1.001; p = 0.016).
Prepectoral two-stage breast reconstruction can be performed safely with an acceptable early complication profile. The study data suggest that increasing mastectomy weight is the most significant factor associated with TE loss. Further research examining the quality of the soft tissue envelope and assessing patient-reported outcomes would prove beneficial.
近年来,用于乳腺癌根治术后乳房重建的胸肌前置植入物的应用有所增加。前肌重建的优点可能包括缺乏动画畸形和减少术后疼痛,但目前其并发症情况尚不清楚。本研究旨在检查胸肌前置组织扩张器(TE)的并发症情况,以确定与 TE 丢失相关的因素。
对 2018 年 1 月至 2021 年 6 月期间接受即刻胸肌前置 TE 重建的所有患者进行回顾性研究。采用胸肌前置技术的决定基于乳房切除术皮肤质量和患者合并症。评估了患者的人口统计学、合并症和手术细节。感兴趣的结果包括 TE 丢失、血清肿、血肿、感染/蜂窝织炎、需要修复的乳房切除术皮瓣坏死和 TE 暴露。采用逻辑回归分析确定与 TE 丢失相关的因素。
研究确定了 1225 个 TE。最常见的并发症是血清肿(8.7%,n=106)、感染/蜂窝织炎(8.2%,n=101)和 TE 丢失(4.2%,n=51)。单因素分析中与 TE 丢失相关的因素包括种族、吸烟史、体重指数、乳房切除术重量和新辅助化疗。多变量回归分析中,只有乳房切除术重量与 TE 丢失呈正相关(优势比,1.001;p=0.016)。
胸肌前置两阶段乳房重建可以安全进行,早期并发症情况可接受。研究数据表明,乳房切除术重量的增加是与 TE 丢失最显著相关的因素。进一步研究检查软组织包的质量并评估患者报告的结果将是有益的。